Literature DB >> 19603415

Effects of resveratrol analogs on steroidogenesis and mitochondrial function in rat Leydig cells in vitro.

Konstantin Svechnikov1, Carmela Spatafora, Irina Svechnikova, Corrado Tringali, Olle Söder.   

Abstract

Resveratrol and its analogs are considered to be a promising drug candidate for treatment of cancer and different age-associated diseases. In the present study we have investigated the effects of resveratrol and its synthetic analogs on steroidogenesis and mitochondrial function in primary cultures of rat Leydig cells. Our findings indicate that resveratrol and its analogs structure-dependently attenuated hCG-activated steroidogenesis in Leydig cells through suppression of the expression of steroidogenic acute regulatory protein and cytochrome P450c17. 3,5-Diacetyl resveratrol was observed to modulate mitochondrial function in Leydig cells, suppressing polarization of inner mitochondrial membrane, and 3,4,4'-trimethoxystilbene stimulated the overall activity of intracellular reductases involved in the reduction of WST-1 to formazan. Thus, the inhibitory actions of resveratrol analogs on steroidogenesis in Leydig cells indicate novel mechanisms of action of these compounds, which may be of potential therapeutic interest, where suppression of androgen action is needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19603415     DOI: 10.1002/jat.1456

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  14 in total

1.  Resveratrol reduces steroidogenesis in rat ovarian theca-interstitial cells: the role of inhibition of Akt/PKB signaling pathway.

Authors:  Israel Ortega; Jesus A Villanueva; Donna H Wong; Amanda B Cress; Anna Sokalska; Scott D Stanley; Antoni J Duleba
Journal:  Endocrinology       Date:  2012-06-19       Impact factor: 4.736

Review 2.  Endocrine disruptors and Leydig cell function.

Authors:  K Svechnikov; G Izzo; L Landreh; J Weisser; O Söder
Journal:  J Biomed Biotechnol       Date:  2010-08-25

3.  Resveratrol protects the ovary against chromium-toxicity by enhancing endogenous antioxidant enzymes and inhibiting metabolic clearance of estradiol.

Authors:  Sakhila K Banu; Jone A Stanley; Kirthiram K Sivakumar; Joe A Arosh; Robert C Burghardt
Journal:  Toxicol Appl Pharmacol       Date:  2016-04-27       Impact factor: 4.219

4.  A cell-autonomous molecular cascade initiated by AMP-activated protein kinase represses steroidogenesis.

Authors:  Houssein S Abdou; Francis Bergeron; Jacques J Tremblay
Journal:  Mol Cell Biol       Date:  2014-09-15       Impact factor: 4.272

5.  Morphological and transcriptomic alterations in neonatal lamb testes following developmental exposure to low-level environmental chemical mixture.

Authors:  Chris S Elcombe; Ana Monteiro; Mohammad Ghasemzadeh-Hasankolaei; Neil P Evans; Michelle Bellingham
Journal:  Environ Toxicol Pharmacol       Date:  2021-05-05       Impact factor: 5.785

Review 6.  Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome.

Authors:  Asieh Mansour; Saeed Hosseini; Bagher Larijani; Mohammad Reza Mohajeri-Tehrani
Journal:  EXCLI J       Date:  2016-09-05       Impact factor: 4.068

7.  Resveratrol inhibits androgen production of human adrenocortical H295R cells by lowering CYP17 and CYP21 expression and activities.

Authors:  Nesa Marti; Nadia Bouchoucha; Kay-Sara Sauter; Christa E Flück
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

Review 8.  Impact of 5'-amp-activated Protein Kinase on Male Gonad and Spermatozoa Functions.

Authors:  Thi Mong Diep Nguyen
Journal:  Front Cell Dev Biol       Date:  2017-03-23

Review 9.  AMPK: a master energy regulator for gonadal function.

Authors:  Michael J Bertoldo; Melanie Faure; Joëlle Dupont; Pascal Froment
Journal:  Front Neurosci       Date:  2015-07-14       Impact factor: 4.677

10.  Endurance exercise and conjugated linoleic acid (CLA) supplementation up-regulate CYP17A1 and stimulate testosterone biosynthesis.

Authors:  Rosario Barone; Filippo Macaluso; Patrizia Catanese; Antonella Marino Gammazza; Luigi Rizzuto; Paola Marozzi; Giuseppe Lo Giudice; Tomaso Stampone; Francesco Cappello; Giuseppe Morici; Giovanni Zummo; Felicia Farina; Valentina Di Felice
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.